Skip to main content
. 2018 Oct 15;41(1):191–201. doi: 10.3892/or.2018.6794

Figure 5.

Figure 5.

(A) Expression level of GLIS2 in cancer tissues. (B) Prognostic value of GLIS2 at different expression levels among gastric cancer patients. Survival analysis of patients with gastric cancer was performed based on GLIS2 expression, as assessed with online tools. (C) Overall survival time; (D) disease-free survival time. *P<0.05. HR, hazard ratio; CI, confidence interval; GLIS2, GLIS family zinc finger 2; PR, partial response to chemotherapy; CR, complete response to chemotherapy.